Squarepoint’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Sell
109,161
-68,517
-39% -$738K ﹤0.01% 2499
2026
Q1
$1.5M Buy
+177,678
New +$1.94M ﹤0.01% 2424
2025
Q4
Sell
-241,423
Closed -$3.62M 4278
2025
Q3
$3.62M Buy
+241,423
New +$3.51M ﹤0.01% 1655
2024
Q4
Sell
-42,754
Closed -$1.99M 5025
2024
Q3
$2.14M Buy
42,754
+25,690
+151% +$999K ﹤0.01% 2024
2024
Q2
$592K Buy
+17,064
New +$675K ﹤0.01% 2953
2023
Q3
Sell
-38,588
Closed -$923K 3789
2023
Q2
$923K Sell
38,588
-101,344
-72% -$1.74M ﹤0.01% 2219
2023
Q1
$1.91M Buy
+139,932
New +$2.23M 0.01% 1441

Other funds holding BHVN

Squarepoint's BHVN Position: Q2 2026 in Review

Squarepoint reduced its Biohaven (BHVN) stake by 39% in Q2 2026, selling an estimated $738K and leaving 109,161 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2499.

Squarepoint first reported a position in BHVN in Q1 2023 and has held it in 7 quarters since. The position peaked at $3.62M in Q3 2025. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Squarepoint held 109,161 shares of Biohaven worth $1.62M as of Q2 2026.
  • Squarepoint sold 68,517 Biohaven shares in Q2 2026, an estimated $738K.
  • Biohaven made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2499 holding.
  • Squarepoint first reported a position in Biohaven in Q1 2023 and has held it in 7 quarters since.
  • Squarepoint's Biohaven position peaked at $3.62M in Q3 2025.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.